Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carol A Watson

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Thrombosis and Thrombolysis|February 27, 2007
Razaxaban, a direct factor Xa inhibitor, in combination with aspirin and/or clopidogrel improves low-dose antithrombotic activity without enhancing bleeding liability in rabbitsPancras C Wong, Earl J Crain, Carol A Watson, et al.
Journal of Cardiovascular Pharmacology|May 22, 2007
Platelet aggregometry and receptor binding to predict the magnitude of antithrombotic and bleeding time effects of clopidogrel in rabbitsPancras C Wong, Earl J Crain, Carol A Watson, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 20, 2002
Nonpeptide factor Xa inhibitors III: effects of DPC423, an orally-active pyrazole antithrombotic agent, on arterial thrombosis in rabbitsPancras C Wong, Earl J Crain, Carol A Watson, et al.
Journal of Thrombosis and Thrombolysis|August 8, 2015
In vitro, antithrombotic and bleeding time studies of BMS-654457, a small-molecule, reversible and direct inhibitor of factor XIaPancras C Wong, Mimi L Quan, Carol A Watson, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
Discovery of a Potent Parenterally Administered Factor XIa Inhibitor with Hydroxyquinolin-2(1H)-one as the P2' MoietyZilun Hu, Pancras C Wong, Paul J Gilligan, et al.
Journal of Medicinal Chemistry|January 11, 2014
Tetrahydroquinoline derivatives as potent and selective factor XIa inhibitorsMimi L Quan, Pancras C Wong, Cailan Wang, et al.
Bioorganic & Medicinal Chemistry Letters|April 23, 2013
Discovery of diarylurea P2Y(1) antagonists with improved aqueous solubilityTammy C Wang, Jennifer X Qiao, Charles G Clark, et al.
Science Translational Medicine|January 6, 2017
Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleedingPancras C Wong, Dietmar Seiffert, J Eileen Bird, et al.
Journal of Medicinal Chemistry|November 19, 2014
Phenylimidazoles as potent and selective inhibitors of coagulation factor XIa with in vivo antithrombotic activityJon J Hangeland, Todd J Friends, Karen A Rossi, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Thrombosis and Thrombolysis|February 27, 2007
Razaxaban, a direct factor Xa inhibitor, in combination with aspirin and/or clopidogrel improves low-dose antithrombotic activity without enhancing bleeding liability in rabbitsPancras C Wong, Earl J Crain, Carol A Watson, et al.
Journal of Cardiovascular Pharmacology|May 22, 2007
Platelet aggregometry and receptor binding to predict the magnitude of antithrombotic and bleeding time effects of clopidogrel in rabbitsPancras C Wong, Earl J Crain, Carol A Watson, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 20, 2002
Nonpeptide factor Xa inhibitors III: effects of DPC423, an orally-active pyrazole antithrombotic agent, on arterial thrombosis in rabbitsPancras C Wong, Earl J Crain, Carol A Watson, et al.
Journal of Thrombosis and Thrombolysis|August 8, 2015
In vitro, antithrombotic and bleeding time studies of BMS-654457, a small-molecule, reversible and direct inhibitor of factor XIaPancras C Wong, Mimi L Quan, Carol A Watson, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
Discovery of a Potent Parenterally Administered Factor XIa Inhibitor with Hydroxyquinolin-2(1H)-one as the P2' MoietyZilun Hu, Pancras C Wong, Paul J Gilligan, et al.
Journal of Medicinal Chemistry|January 11, 2014
Tetrahydroquinoline derivatives as potent and selective factor XIa inhibitorsMimi L Quan, Pancras C Wong, Cailan Wang, et al.
Bioorganic & Medicinal Chemistry Letters|April 23, 2013
Discovery of diarylurea P2Y(1) antagonists with improved aqueous solubilityTammy C Wang, Jennifer X Qiao, Charles G Clark, et al.
Science Translational Medicine|January 6, 2017
Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleedingPancras C Wong, Dietmar Seiffert, J Eileen Bird, et al.
Journal of Medicinal Chemistry|November 19, 2014
Phenylimidazoles as potent and selective inhibitors of coagulation factor XIa with in vivo antithrombotic activityJon J Hangeland, Todd J Friends, Karen A Rossi, et al.
Pageof 2